These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28750322)

  • 1. Longitudinal sequencing of HIV-1 infected patients with low-level viremia for years while on ART shows no indications for genetic evolution of the virus.
    Vancoillie L; Hebberecht L; Dauwe K; Demecheleer E; Dinakis S; Vaneechoutte D; Mortier V; Verhofstede C
    Virology; 2017 Oct; 510():185-193. PubMed ID: 28750322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus.
    Tobin NH; Learn GH; Holte SE; Wang Y; Melvin AJ; McKernan JL; Pawluk DM; Mohan KM; Lewis PF; Mullins JI; Frenkel LM
    J Virol; 2005 Aug; 79(15):9625-34. PubMed ID: 16014925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phylogenetic evidence of HIV-1 sequence evolution in subjects with persistent low-level viraemia.
    Vardhanabhuti S; Taiwo B; Kuritzkes DR; Eron JJ; Bosch RJ
    Antivir Ther; 2015; 20(1):73-6. PubMed ID: 24699164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between latent proviral characteristics and immune activation in antiretrovirus-treated human immunodeficiency virus type 1-infected adults.
    Liang EC; Sceats L; Bayless NL; Strauss-Albee DM; Kubo J; Grant PM; Furman D; Desai M; Katzenstein DA; Davis MM; Zolopa AR; Blish CA
    J Virol; 2014 Aug; 88(15):8629-39. PubMed ID: 24850730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution and recombination of genes encoding HIV-1 drug resistance and tropism during antiretroviral therapy.
    Shi B; Kitchen C; Weiser B; Mayers D; Foley B; Kemal K; Anastos K; Suchard M; Parker M; Brunner C; Burger H
    Virology; 2010 Aug; 404(1):5-20. PubMed ID: 20451945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monotypic low-level HIV viremias during antiretroviral therapy are associated with disproportionate production of X4 virions and systemic immune activation.
    Bull ME; Mitchell C; Soria J; Styrchak S; Williams-Wietzikoski C; Legard J; McKernan-Mullin J; Kraft K; Onchiri F; Stern J; Holte S; Ryan KJ; Acosta EP; La Rosa A; Coombs RW; Ticona E; Frenkel LM
    AIDS; 2018 Jul; 32(11):1389-1401. PubMed ID: 29683841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy.
    Raymond S; Saliou A; Delobel P; Cazabat M; Pasquier C; Jeanne N; Sauné K; Massip P; Marchou B; Izopet J
    J Antimicrob Chemother; 2014 Sep; 69(9):2527-30. PubMed ID: 24840625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 persistent viremia is frequently followed by episodes of low-level viremia.
    Widera M; Dirks M; Bleekmann B; Jablonka R; Däumer M; Walter H; Ehret R; Verheyen J; Esser S
    Med Microbiol Immunol; 2017 Jun; 206(3):203-215. PubMed ID: 28220254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer.
    Rose R; Lamers SL; Nolan DJ; Maidji E; Faria NR; Pybus OG; Dollar JJ; Maruniak SA; McAvoy AC; Salemi M; Stoddart CA; Singer EJ; McGrath MS
    J Virol; 2016 Oct; 90(20):8984-93. PubMed ID: 27466425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients.
    Delaugerre C; Gallien S; Flandre P; Mathez D; Amarsy R; Ferret S; Timsit J; Molina JM; de Truchis P
    PLoS One; 2012; 7(5):e36673. PubMed ID: 22590588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.
    Laprise C; de Pokomandy A; Baril JG; Dufresne S; Trottier H
    Clin Infect Dis; 2013 Nov; 57(10):1489-96. PubMed ID: 23946221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with high-risk low-level viremia leading to virologic failure: 16-year retrospective study of a Chinese antiretroviral therapy cohort.
    Zhang T; Ding H; An M; Wang X; Tian W; Zhao B; Han X
    BMC Infect Dis; 2020 Feb; 20(1):147. PubMed ID: 32066392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of virological failure in HIV-1-infected patients experiencing low-level viraemia under active antiretroviral therapy (ANRS C03 cohort study).
    Vandenhende MA; Perrier A; Bonnet F; Lazaro E; Cazanave C; Reigadas S; Chêne G; Morlat P;
    Antivir Ther; 2015; 20(6):655-60. PubMed ID: 25735799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An increasing proportion of monotypic HIV-1 DNA sequences during antiretroviral treatment suggests proliferation of HIV-infected cells.
    Wagner TA; McKernan JL; Tobin NH; Tapia KA; Mullins JI; Frenkel LM
    J Virol; 2013 Feb; 87(3):1770-8. PubMed ID: 23175380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-level HIV-1 viraemia in patients on HAART: risk factors and management in clinical practice.
    Wirden M; Todesco E; Valantin MA; Lambert-Niclot S; Simon A; Calin R; Tubiana R; Peytavin G; Katlama C; Calvez V; Marcelin AG
    J Antimicrob Chemother; 2015 Aug; 70(8):2347-53. PubMed ID: 25921516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals.
    Gonzalez-Serna A; Min JE; Woods C; Chan D; Lima VD; Montaner JS; Harrigan PR; Swenson LC
    Clin Infect Dis; 2014 Apr; 58(8):1165-73. PubMed ID: 24429436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells.
    Anderson JA; Archin NM; Ince W; Parker D; Wiegand A; Coffin JM; Kuruc J; Eron J; Swanstrom R; Margolis DM
    J Virol; 2011 May; 85(10):5220-3. PubMed ID: 21367910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.
    Puertas MC; Noguera-Julian M; Massanella M; Pou C; Buzon MJ; Clotet B; Stevenson M; Paredes R; Blanco J; Martinez-Picado J
    Retrovirology; 2016 Aug; 13(1):51. PubMed ID: 27484989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcome.
    Charpentier C; Landman R; Laouénan C; Joly V; Hamet G; Damond F; Brun-Vézinet F; Mentré F; Descamps D; Yeni P
    J Antimicrob Chemother; 2012 Sep; 67(9):2231-5. PubMed ID: 22643190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.